Personalized cancer vaccine shows potential in kidney cancer
In a Phase 1 study, nine people with advanced kidney cancer became cancer free after receiving personalized vaccines.
Related Articles
‘Biggest data breach in history’: Labor unions sue Trump admin over Treasury takeover, with healthcare privacy impacts far-ranging
Two government labor unions and an advocacy group are suing the Department of Treasury and the Bureau of the Fiscal Service over Elon Musk and…
What happens when a rare disease drug seems to work, but the health care system doesn’t?
Cristina Brennan can hear the clock ticking. At the end of the year, her 12-year-old son Tristan will no longer have free access to a…
A Randomized, Controlled Trial of In-Hospital Use of Virtual Reality to Reduce Preoperative Anxiety Prior to Cardiac Surgery
To study the effectiveness of virtual reality (VR) in reducing anxiety levels in patients undergoing first-time sternotomy for cardiac surgery.
More than half a billion dollars burned by Starliner in 2024
More Catastrophic Capsule than Calamity Capsule for Boeing’s beancounters
Physicians of the Future Summit
The Medical Student Section (MSS) will hold its virtual Physicians of the Future Summit on Feb. 8, 2025. Register today!
International Stroke Congress (ISC) Articles | JAMA Network
International Stroke Congress (ISC) Articles | JAMA Network International Stroke Conference (ISC) QUICK LINKS: Visit Us at ISC For Authors More Articles QUICK LINKS Visit…
Unlocking Treatment Possibilities in PBC
For US Healthcare Professionals Rush University Medical Center Chicago, IL Liver Institute Northwest Seattle, WA Weill Cornell Medical College New York, NY Rush University Medical…
FDA Approves Novel Non-Opioid Pain Reliever
The first-of-its-kind medication could be especially beneficial to older adults
Pfizer Announces New Chief Oncology Officer | Pfizer
New York, February 5, 2025 – Pfizer Inc. (NYSE: PFE) today announced that Jeffrey Legos, PhD, MBA, will join the company as Chief Oncology Officer.…
Pfizer is about to make a big push in cancer. Will investors listen?
Pfizer has a big problem. The drug giant hopes that new drugs to treat cancer are the solution.